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iNtRoDuctioN
Nipple discharge is a relatively frequent event in females, 
being the third most common breast symptoms prompting 
medical care, after breast pain and breast palpable mass. 
Over 80% of females will develop an episode of nipple 
discharge during their fertile life,1 which can be categorized 
as lactional, physiological, and pathological according to 
the clinical history and the characteristics of the discharge.
Lactional nipple discharge is considered as a normal milk 
production. It is expected during pregnancy and lactation 
and may persist for up to one year post-partum or after 
cessation of breastfeeding. When a milky nipple discharge 
occurs in females without recent history of pregnancy or 
lactation it is called galactorrhea and commonly involves 
bilateral multiple duct being the result of an inappropriate 
increase in prolactin release, usually supported by a prolac-
tinoma, a prolactin-producing benign tumor of pituitary 
gland.2
Physiological nipple discharge is a benign entity, usually 
bilateral and white, green, or yellow in color. It involves 
multiple ducts and is associated with nipple squeezing. 
Some causes of physiological nipple discharge are hypothy-
roidism and medication side-effects.3
Pathologic nipple discharge (PND) is defined as a clear, 
serous, or bloody secretion (not green or milky), sponta-
neous, discharging from a single duct and unilateral. It is 
frequently caused by a benign lesion, such as intraductal 
papilloma(s) (35–56% of cases) or ductal ectasia (6–59%), 
but an underlying malignancy can be present in a percentage 
of cases reported to be variable from 5 to 33%.3–12
According to literature,4,5,11,13–16 the first diagnostic 
work-up of females with nipple discharge includes clinical 
history and physical examination. Although conventional 
imaging, including mammography and ultrasonography 
are usually performed, these investigations are not always 
able to exclude an underlying malignancy. More in-depth 
investigations are proposed such as galactography, ductos-
copy, and MRI.
Because to differentiate between a benign from a malignant 
etiology of a PND based on clinical and diagnostic assess-
ment is not easy, surgical excision has been considered the 
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Over 80% of females experience nipple discharge during their life. Differently from lactational (milk production) and 
physiological (white, green, or yellow), which are usually bilateral and involving multiple ducts, pathologic nipple 
discharge (PND) is a spontaneous commonly single-duct and unilateral, clear, serous, or bloody secretion. Mostly 
caused by intraductal papilloma(s) or ductal ectasia, in 5-33% of cases is due to an underlying malignancy. After clinical 
history and physical examination, mammography is the first step after 39, but its sensitivity is low (7–26%). Ultrasound 
shows higher sensitivity (63–100%). Nipple discharge cytology is limited by a false negative rate over 50%. Galactog-
raphy is an invasive technique that may cause discomfort and pain; it can be performed only when the duct discharge 
is demonstrated at the time of the study, with incomplete/failed examination rate up to 15% and a difficult differentia-
tion between malignant and benign lesions. Ductoscopy, performed under local anesthesia in outpatients, provides a 
direct visualization of intraductal lesions, allowing for directed excision and facilitating a targeted surgery. Its sensitivity 
reaches 94%; however, it is available in only few centers and most clinicians are unfamiliar with its use. PND has recently 
emerged as a new indication for contrast-enhanced breast MRI, showing sensitivity superior to galactography, with an 
overall sensitivity up to 96%, also allowing tailored surgery. Surgery no longer can be considered the standard approach 
to PND. We propose a state-of-the art flowchart for the management of nipple discharge, including ductoscopy and 
breast MRI as best options.
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main way for getting both definitive diagnosis and eliminating 
the symptom.17
In this article, we try to define a state of the art of management of 
patients with nipple discharge.
cliNicAl HistoRY AND PHYsicAl 
eXAMiNAtioN
Clinical history plays an important role for evaluating the prob-
ability of malignancy. BRCA1/2 mutations, history of ipsilateral 
cancer, and age over 50 years are predicting factors for malig-
nancy in the presence of PND.18 In a study including 318 patients 
with nipple discharge (any fluid from the nipple, spontaneous 
discharge or observed during breast examination), Seltzer19 
has reported a higher incidence of breast cancer equal to 9% 
in females over 50 (95 patients and 9 cancers) while the inci-
dence was of only 1.3% in younger patients (223 patients and 3 
cancers). Previous breast biopsy with diagnosis of atypia is also 
considered a predictor of malignancy.20
Physical examination has the aim of distinguishing between 
benign and pathological discharge and of verifying the pres-
ence of palpable mass or other associated findings. It usually 
includes a complete breast evaluation with inspection and palpa-
tion, followed by a focused inspection of the nipple area using 
a magnifying lamp. The physical examination is essential to 
investigate the color of discharge, the number of ducts involved, 
the frequency of discharge (persistent or intermittent), and if it 
is unilateral or bilateral. A spontaneous single-pore bloody and 
clear discharge is suspect for pathological discharge.
MAMMoGRAPHY
Mammography represents the first conventional imaging tech-
nique to investigate nipple discharge, at least after 39 years old. 
For patients with PND, aged between 30 and 40 years old with 
high-familiarity risk, mammography could be appropriated in 
order to exclude the presence of microcalcification, as well as for 
females younger than 30 of age when initial ultrasound shows 
suspicious findings.9 The protocol includes the standard cranio-
caudal and mediolateral oblique views.
Mammography findings that are suspect to be associated to an 
occult malignancy can range from microcalcifications, masses, 
focal density asymmetry, architectural distortion or ductal 
ectasia, or otherwise no abnormality can be identified. Mammog-
raphy has low sensitivity and limited accuracy in the detection of 
retroareolar lesions that are often small, intraductal, and without 
calcifications.5 Ductal ectasia may occur as a general increase in 
density of the retroareolar region and in order to better visualize 
the area spot compression views could be performed.
In order to improve spatial resolution, magnification mammog-
raphy can be performed to identify microcalcifications and to 
distinguish between benign or malignant duct disease.
Microcalcifications with branching or linear pattern, vari-
able density, or distributed in a segmental way, are all highly 
suspicious of malignancy, whereas round or rod-like calcifica-
tions suggest for benign disease.
Bahl et al11 studied 252 patients with at least one pathological feature 
of nipple discharge (unilateral, clear or bloody, or spontaneous 
discharge) who underwent surgical excision or a 2-year follow-up. 
Of 20 cancers diagnosed, only 3 were revealed by mammography, 
with a 15% (3/20) sensitivity. In other studies,5,21,22 the sensitivity of 
mammography ranged from 7 to 26%.
ultRAsouND
Ultrasound offers a better performance than mammography for 
detecting intraductal lesions.3 Ductal ectasia, defined by a duct 
caliber greater than 3 mm, is one of the most common findings 
well seen on ultrasound and it appears as dilated retroareolar 
ducts containing anechoid fluid or hypoecoic debris. It is often 
caused by intraductal papilloma appearing as a hypoechoic 
nodule with a central vascular pedicle on color Doppler. Doppler 
ultrasound is helpful in differentiating intraductal viscous secre-
tion versus intraductal nodule with vascular sign. Irregular duct 
margins, wall thickening or hypoechoic intraductal mass with 
acoustic shadowing are ultrasound malignant features.
In a study5 evaluating 38 patients with nipple discharge (32 of 
them with PND) with mammography and ultrasound, the overall 
sensitivity for malignant and high-risk lesions (papillomas and 
atypical intraductal hyperplasia) were 26% for mammography 
and 63% for ultrasound; specificity was 94% and 84%, respec-
tively. In another study,23 the sensitivity of ultrasound for cancer 
was 100% (8/8) and the specificity was 73% (102/140). When 
compared to mammography, ultrasound improves the evalu-
ation of the retroareolar region and ductal system that can be 
obscured in patients with dense breasts.24
In a study by Park et al15 the detection rate of malignant lesions 
occult on mammography and ultrasound-detected was reported 
to be 8 of 53 females with PND examined (15%). Yoon et al25 
have also reported that adding ultrasound to mammography in 
the pre-operative setting of PND led to the detection of malig-
nancies in 26% of patients (ultrasound detected 5 breast cancers 
in addition to the 19 breast cancers found by mammography).
The role of ultrasound elastography is disputable in predicting 
malignancy in patients with PND. Guo et al16 have evaluated 
the diagnostic accuracy of elastography in patients with PND, 
affirming that it is a useful tool for predicting malignancy, with 
sensitivity for malignancy of 90% and that it could be used as a 
helpful test before more invasive examination (such as ductos-
copy or duct excision). However, it is only a preliminary study 
and further studies are needed to verify the diagnostic perfor-
mance of elastography.
NiPPle DiscHARGe cYtoloGY
Nipple discharge cytology is performed by squeezing the nipple 
with a gentle compression of the areola area and spreading the 
secretion onto a glass slide. After smearing, the slides are imme-
diately fixed by spray fixation or by immersion in 95% ethyl 
alcohol and then stained with the Papanicolaou stain.3
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It is a simple and fast examination, easy to perform and painless, 
but strongly limited by a low sensitivity for cancer, with a false 
negative rate over 50%.3,5,26–29 Moreover, it can be technically 
impossible when discharge is not present on the moment of the 
examination. According to the American College of Radiology, 
this examination has not proven to be effective in differentiating 
benign from malignant lesions.9 Therefore, discharge cytology 
is not routinely recommended.10 Nipple discharge smears are 
classified as abnormal if they contained papillary, atypical, suspi-
cious, or malignant cells; malignant nipple discharge cytology 
(C4-C5 categories) is correlated with more high-specificity 
values.30
GAlActoGRAPHY
For a long time, galactography (also called ductography, or 
ductogalactography) has been considered the gold standard 
to assess PND before surgery. It is performed by cannulating 
the discharging duct with a blunt dedicated cannula, through 
which non-ionic iodined contrast agent is injected. Usually a 
volume of 0.5–1.0 ml of iodined contrast material is adminis-
tered. After contrast injection, the breast is compressed and stan-
dard mammogram is obtained (craniocaudal and mediolateral 
oblique projections). At the end of examination, the contrast 
material is aspirated with the same syringe that was used to 
inject it and gentle manual pressure is exerted on the breast 
to discharge it. All the procedure usually takes about 15 min31 
but longer times are sometimes required. Contraindications to 
galactography include severe allergy to iodinated contrast mate-
rial and a history of prior nipple surgery that would completely 
disconnect the nipple pores from the underlying ducts. The 
resulting ductograms are classified as normal or showing ductal 
ectasia (i.e. duct diameter over 2 mm), filling interruption, filling 
stops, and ductal distortions.32
Nowadays, galactography has lost some of its clinical relevance 
due to many disadvantages of the investigation and the avail-
ability of other options. As reported by Scheurlen et al33 in a 
recent systematic review, “galactography can no longer be consid-
ered as a mandatory standard in modern multimodal imaging 
of the breast”. Indeed, it is an invasive technique and may cause 
discomfort and pain.9 Galactography can also be performed only 
when the duct discharge is demonstrated at the time of the study. 
Therefore it can be technically impossible, especially in patients 
with intermittent discharge or nipple retraction.10,34 Duct 
rupture can happen if too much contrast material or pressure is 
used during injection. The incomplete or failed galactography 
rate has been reported as high as 15%.6
Galactography allows to visualize and localize intraductal lesions, 
but usually it does not allow to differentiate between benign and 
malignant pathology.1,4,34
DuctoscoPY
Differently from galactography, ductoscopy provides a direct 
visualization of intraductal lesions, allowing for directed exci-
sion and facilitating a targeted surgery. The benefit is being able 
to avoid extensive surgery resection with healthy breast tissue 
conservation.35
The offending duct is identified through gentle pressure on the 
areola and noticing the source of discharge and the ductal orifice 
is dilated with a suitable probe. The micro-endoscope (0.9 mm 
in size) is inserted through the duct and a saline solution is 
injected through the working channel (0.2 mm in size) of the 
endoscope to obtain a clear visualization of the intraductal space. 
The injection of saline solution permits to do a ductal lavage and 
the lavage effluent can be also collected for cytological examina-
tion. The major duct and all the branches are inspected to the 
maximum depth possible according to the ductal size (median 
depth 5–6 cm).35 Limitation is related to the length and to the 
outer diameter of the scope, in that the ductoscope cannot reach 
the far and minute ductal branches with the risk of not seeing 
lesions in these ductal branches.36
It can be performed under local anesthesia in outpatients 
increasing patient tolerability and decreasing risk and possible 
complications.37 In the case of a dilated nipple orifice, the 
cannulation can be easier. According to the literature, there are 
contradictory views about the correlation between intraductal 
visual observations and histopathological diagnosis. Despite 
some researchers stating a significant correlation, and therefore 
intraductal visual observations seem to be sufficient to charac-
terize lesion, others affirm that visual inspection alone could 
not be sufficient to differentiate between benign and malignant 
lesions.37,38 Therefore only when no intraductal abnormalities 
are found, ductoscopy is considered negative. Anyway, ductos-
copy has to be considered as an invasive technique and, like for 
galactography, inverted nipples, narrow or unidentifiable ducts, 
obstructing lesions behind the nipple, and pain during the proce-
dure represent relevant substantial obstacles to perform it.37
In a recent systematic review and meta-analysis Waaijer 
et al39 assessed the diagnostic accuracy of ductoscopy in patients 
with PND. Including 12 studies with a total of 1,994 patients, 
for which any intraductal lesion visualized by ductoscopy was 
classified as a positive finding and normal ducts were classi-
fied as negative, ductoscopy detected about 94% of all under-
lying malignancies. Results were compared with histopathology 
outcomes or follow-up for a total of 151 malignancies [invasive 
breast cancer and ductal carcinoma in situ (DCIS)]. Specificity, 
defined as the proportion of females with negative ductoscopy 
among all females with benign outcomes, was low, equal to only 
47%. The authors reported that owing to the high sensitivity 
of ductoscopy and low incidence of malignancy in PND, this 
method has a 98–100% negative predictive value (NPV). Thus, a 
negative ductoscopy could make surgery unnecessary, avoiding 
risk and complications.
Waaijer and coworkers38 also investigated the therapeutic effect 
of ductoscopy in patients with PND without suspected malig-
nancy on routine diagnostic evaluation. 53 abnormalities in 82 
patients were visualized on ductoscopy (n = 29 were polypoid 
lesions) and 27 lesions were removed in 34 attempted ductoscopic 
extractions. In 56 of 82 patients (68%) surgery was avoided.
High sensitivity value of ductoscopy was confirmed by Yilmaz 
et al.40 They compared MRI and ductoscopy, reporting that these 
4 of 9 birpublications.org/bjro BJR Open;1:20180016
BJR|Open  Panzironi et al
techniques have not statistical superiority over each other in the 
diagnosis of intraductal lesion in patients with PND (sensitivity 
was 94% for ductoscopy, 90% for MRI).
Despite these good results, ductoscopy remains still unpop-
ular, it is available in only a few centers and most clinicians are 
unfamiliar with its use. Furthermore, it is difficult to source the 
intraductal needle biopsy devices that are not yet commercially 
available in Europe and in USA, with unresolved issues regarding 
cost and reimbursement.39,41,42
MRi
According to the European recommendations,43 nipple discharge 
has recently emerged as a new indication for breast MRI. In 
fact, it is an effective alternative to galactography, non-invasive 
although it requires the i.v. injection of a gadolinium-based 
contrast material, with an overall sensitivity for breast cancer 
ranging from 90 to 99%.9,43,44
Contrast-enhanced MRI allows detecting a “mass enhancement” 
or “non-mass enhancement” lesions. The main MRI finding in 
patients with PND is “non-mass enhancement”: a segmental 
and linear “non-mass enhancement” is more often associated 
with malignancy. Intraductal papilloma appears as a well-cir-
cumscribed mass with homogeneous enhancement. Other times 
ductal or segmental enhancement can be seen in both papillomas 
and papillomatosis. Dilated ducts appear as signal hyperintensity 
on T2 weighted imaging or as an area of high-signal intensity in 
pre-contrast T1 weighted sequences, if endoluminal high protein 
or hemorrhagic content is present.
Contrast-enhancement MRI allows imaging of both breasts 
with a good visualization of retroareolar regions. It outlines 
enhancing pathology in good detail, thereby providing phys-
iological information in addition to the morphological detail 
provided by mammography and ultrasound.45 It also permits 
to detect multifocal or multicentric disease or to find an occult 
contralateral lesion.46 This MRI ability can play a crucial role 
when a PND involves more than one duct or it is unclear which 
duct is involved (e.g. intermittent suspicious discharge).
These advantages, makes MRI a better tool compared to the 
other diagnostic techniques despite higher cost.
Lorenzon et al5 reported a cancer sensitivity of contrast-en-
hanced MRI of 100% on a small series (5 out of 5 malignancies 
and all associated with PND). Three of these cancers were missed 
at conventional imaging (mammography and ultrasound) and 
detected only with MRI. Other studies compared MRI against 
galactography. Morrogh et al6 studied 306 patients with PND. 
They reported a positive predictive value of 56% and a NPV 
of 87% for contrast-enhanced MRI, while the same data were 
13% and 63% for galactography respectively, concluding that 
galactography cannot exclude malignancy. Manganaro et al34 
evaluated retrospectively 53 patients with unilateral bloody or 
serous-bloody nipple discharge. They found a significant differ-
ence in sensitivity between contrast-enhanced MRI (98%) and 
galactography (49%) to identify ductal pathologies (papilloma, 
papillomatosis, DCIS, papillary carcinoma) and they also found 
a significant association between DCIS and segmental enhance-
ment on MRI.
Berger et al7 demonstrated the accuracy of MRI versus galac-
tography in a systematic review and meta-analysis, including 
10 articles for a total of 921 patients. MRI showed significantly 
higher sensitivity (92%) and specificity (76%) for abnormal find-
ings than galactography (69% and 39%, respectively). When 
considering only breast cancers, MRI sensitivity was 92%, speci-
ficity 97%. These results confirmed on a pooled large case series 
that galactography is outdated and MRI should be performed in 
the presence of PND when conventional imaging is negative or 
inconclusive. Other experiences support the role of MRI in the 
evaluation of patient with nipple discharge and negative conven-
tional imaging.8,14,47 Many authors highlight the value of targeted 
ltrasound looking for suspicious finding on MRI.3,5
According to the latest American research, in about of 60% of 
cases radiologists recommended breast MRI in the setting of 
pathologic nipple discharge after the negative results of diag-
nostic breast imaging.48
Bahl et al47 had reported a NPV of MRI for in situ or invasive 
malignancy of 96% (75/78), from a series of 105 who underwent 
MRI after a negative or inconclusive mammography for evalua-
tion of nipple discharge.
Furthermore, MRI can help to better identify lesions located 
in the deepest areas of breast, at a significant distance from the 
nipple as it is difficult to visualize them with other techniques 
as ductoscopy or galactography. Compared to galactography in 
which only one duct can be cannulated, MRI allows evaluating 
at the same time all the ductal system. Both invasive or in situ 
cancer and papilloma may affect more than one duct. Sanders 
et al13 reported that four of eight cancers detected on MRI were 
located between 3 and 12 cm far from the nipple. Thus, pre-op-
erative MRI should be performed to facilitate optimal treatment 
planning in patients with nipple discharge.14,46,47 Breast MRI is a 
useful diagnostic tool in the characterization of BIRADS (Breast 
Imaging Reporting and Data System) for mammographic micro-
calcifications to exclude malignancy.49
Concerning the MRI protocols for investigating PND, we should 
differentiate the indirect MR-galactogram from direct MR-galac-
tography.50,51 The indirect MR-galactogram accentuates the visi-
bility of structures containing fluids using heavily T2 weighted 
sequences (as is for MR-cholangiography) and avoiding contrast 
material injection and ductal cannulation. By acquiring short 
tau inversion-recovery T2 weighted sequences, and obtaining 
maximum intensity projection images, it permits in a non-in-
vasive way, to obtain images similar with those of galactog-
raphy, with the advantages of receiving great compliance from 
patients and avoiding radiation exposure. Dilated duct shows 
hyperintense signal while intraductal abnormalities appear as 
an hypointense filling defect or filling stop. The spatial resolu-
tion is lower than that of galactography, but the size of malignant 
lesions determining PND (usually at least 2–3 mm) allows this 
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limitation not to be clinically relevant. In addition, it is possible 
to use specific microscopic coil to improve spatial resolution.52
Direct MR-galactography is performed by cannulating the 
discharging duct and directly filling it with contrast mate-
rial. This technique does not save patient from discomfort of 
cannulation and may fail due to the same issues as conventional 
galactography.
Nicholson et al53 compared contrast-enhanced MRI and indirect 
MR-galactography against conventional galactography. They 
found that contrast-enhanced MRI has the highest sensitivity, 
positive and NPVs. Sensitivity for intraductal pathology was 
95% for contrast-enhanced MRI, 52–55% for MR-galactography, 
65% for galactography. Although indirect MR-galactography 
showed interesting results, it is not as sensitive for malignancy 
as is contrast-enhanced MRI. In that study, all of five cancers 
were visualized on contrast-enhanced MRI (three as non-mass 
enhancement and two as mass enhancements) while MR-galac-
tography was negative in three out of five cases (two DCIS and 
one mucinous carcinoma).
Nevertheless, we must consider the false-negative ratings that 
could be low-grade DCIS or very small invasive ductal carcinoma 
due to the lack of enhancement47, as well as the high false posi-
tive rate as reflected by the detection of additional incidental 
lesions afterwards proved negative by biopsy.6
Strobel et al54 reported that MRI assessment has reduced the 
number of false positive findings at mammography from 152 to 
14 after MRI. MRI dismissed three low-grade DCIS (of 25 find-
ings) with a false negative rate of 12%.
Also Manganaro et al34 had only one case of false negative on 
MRI (a DCIS, not identified on galactography). In Lubina’s 
study,8 MRI did not diagnose three cases of low-grade DCIS and 
one invasive carcinoma.
GAlActoGRAPHY coMbiNeD witH 
toMosYNtHesis
Although MRI and ductoscopy represent the innovative tech-
niques in the evaluation of PND, a possible alternative approach 
could be the association between conventional galactography 
with digital breast tomosynthesis. Digital breast tomosynthesis, 
also called three-dimensional mammography, provides sectional 
images from different projection angles with the advantage to 
remove the masking created by overlying structures. It allows 
Figure 1. Flowchart for managing patients with nipple discharge.
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creating digital three-dimensional images with a better localiza-
tion of suspicious findings and higher spatial resolution.
According to Cohen,55 the union of these two techniques could 
be a useful procedure for the workup of PND, especially when 
MR is not available, with a lower cost. However, up to now, there 
is only a recent preliminary original research (based only on five 
patients) that compares ductal sonography with synthetic digital 
two-dimensional full-field mammograms generated using 
contrast-enhanced galactography with tomosynthesis, reporting 
that both techniques were approximately equivalent with respect 
to the correct diagnosis of suspicious findings and the final histo-
pathological results.56 Obviously, the disadvantages of conven-
tional galactography are maintained, including cannulating the 
discharging duct, the direct injection of contrast agent, and radi-
ation exposure.
suRGeRY
For a long time, surgery has been considered the standard 
approach to PND.17 Operation consists of either total subare-
olar duct excision (major duct excision) or selective duct 
excision (microdochectomy) of the single duct affected. The 
benefit of microdochectomy is the preservation of remaining 
ductal systems in continuity with the nipple and is usually the 
best option for young females who wish to breastfeed. In other 
cases major duct excision is preferred due to a higher detec-
tion of occult cancers than that of microdochectomy, resulting 
in fewer patients requiring repeated duct excision.57 Possible 
complications of surgery are inability to breastfeed, loss of nipple 
sensation, and retroareolar necrosis.
Sabel et al18 reported that in 69 patients with PND and normal 
conventional imaging (ultrasound and mammograms), cancer 
was found (after surgery or follow-up) in only 1% of cases (1/69), 
saying that the risk of an occult malignant lesion is relatively low 
in patients without abnormal findings at clinical examination 
and imaging tests. Most of these cases are low-grade DCIS with 
very good prognosis.18 MRI showed high sensitivity and NPV, 
being an accurate imaging test in the workup of nipple discharge 
in patients with inconspicuous mammography and ultrasound.8 
Therefore, surgery cannot be longer always considered the best 
option and the potential of imaging should be more extensively 
explored.
Figure 2.A 40-year-old female with dense breast and 4 
months of pathological discharge from left nipple. Digital 
mammography (craniocaudal and mediolateral-oblique 
views) reveals scattered areas of fibroglandular density with 
no evidence of masses or suspicious calcifications (A). The 
unenhanced T1 weighted image in the axial plane shows ductal 
ectasia in the inner quadrant with endoluminal proteinaceous 
material (head of arrow) (B). The contrast-enhanced axial T1 
weighted image (C) and T1 weighted subtracted maximum 
intensity projection reconstruction (D) revealed an extensive 
segmental enhancement at the inner quadrants of the left 
breast (arrows). Findings were confirmed at pathology to be 
invasive ductal carcinoma of the breast.
Figure 3. A 75-year-old female with 6 months of pathological 
discharge from the left nipple. Duct ectasia was diagnosed on 
ultrasound. No abnormal findings were found on mammog-
raphy. Cytology of discharge showed amorphous material, 
red cells, and macrofages without ductal cell. Galactography 
allowed for a good visualization of the main duct with a filling 
stop for secondary ducts (arrow) (A, B). Contrast-enhanced 
subtracted axial MR images show an enhancing spiculated 
mass at the upper inner quadrant of left breast (arrow in C) 
associated with a segmental non-mass enhancement (circle in 
D). At pathology, an invasive ductal carcinoma with extensive 
intraductal component was revealed.
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In 2014, Ashfaq et al23 proposed again the treatment algorithm 
already envisaged by Gray in 2007,58 suggesting a distinction 
among PND patients between a high-risk group requiring 
surgery versus a low-risk group in whom a short-term surveil-
lance is reasonable. Low-risk patients include those without 
abnormal findings on clinical and radiological assessment that 
can be monitored every 6 months up to 2 years or until the 
discharge resolved, with physical and ultrasound examinations 
every 6 months and yearly mammogram. High-risk patients 
include those with history or family history of breast cancer and 
they should undergo duct excision. In addition, duct excision 
could also be proposed as palliative therapy or in the event of 
refusal of surveillance.18 By using this approach, Ashfaq et al23 
have determined that it is possible to avoid unnecessary opera-
tion in 66% of patients with PND, by reserving it only in selective 
cases. They also documented that among the patients who never 
underwent operation, 81% had a resolution of their discharge.
A FlowcHARt FoR tHe MANAGeMeNt oF 
NiPPle DiscHARGe
We propose here a flowchart for the management of nipple 
discharge (Figure 1). Evaluation of clinical history and physical 
examination are the first approaches to differentiate pathological 
from physiological discharge. Bloody or serous, spontaneous and 
unilateral nipple discharge from a single pore should be consid-
ered suspicious for breast cancer.
Diagnostic imaging evaluation should be performed in all 
females with PND and mammography and breast ultrasound are 
the first examinations to do. Discharge cytology is not routinely 
recommended9 (and it is not considered in this flowchart), but it 
may be useful if combined with other finding.
Contrast-enhanced MRI, due to its highest sensibility and 
NPV should be considered in the management of all patients 
with PND, in particular in those with negative mammography 
and ultrasound9 (Figures  2 and 3). MRI provides excellent 
visualization of dilated ducts and their contents and it outlines 
enhancing pathology in good detail, adding physiological 
information to the morphological detail provided by mammog-
raphy and ultraound.45 When MRI reveals a suspicious lesion 
that can be the cause of the discharge (confirmed or not 
confirmed at conventional modalities), image-guided needle 
biopsy should be performed before sending the patient to 
surgery. If technically possible, ultrasound-guided biopsy 
should be preferred.
In all cases of non-palpable lesions, an image-guided localiza-
tion is needed for pre-operative localization. Based on the low 
risk of underlying malignancy, patients with negative imaging 
(which includes MRI) can be (re)directed to routine screening 
follow-up.5,14,47 When, despite a negative MRI, a suspect lesion 
is found on conventional imaging, ultrasound- or mammogra-
phy-guided biopsy is recommended. Malignancy cases sent to 
surgery and patients with benign lesions should be followed-up 
with routine screening examinations.
If nipple discharge is persistent or recurrent after a 2-year moni-
toring or for patient choice for symptomatic relief, duct excision 
may be considered.
In the presence of physiological nipple discharge, image-guided 
biopsy is recommended just in case of abnormalities at conven-
tional imaging; otherwise routine follow-up should be done.9 
MRI is not appropriate in cases of physiological discharge and 
negative conventional imaging, but can be proposed in the case 
of malignancy to evaluate the extension of disease.
In conclusion, clinical history and physical examination, 
mammography, and ultrasound remain important steps in the 
management of patient with nipple discharge, despite their low 
diagnostic accuracy. Discharge cytology has a low diagnostic 
value, and is not routinely recommended. Galactography might 
not be the best option due to its disadvantages and the increasing 
availability of MRI and ductoscopy. Unlike in the past years, 
surgery should no longer be considered the standard of care 
in patients with PND. Performing an MRI is recommended in 
those patients.
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